<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27836834</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>11</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1943-0264</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Jan</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cold Spring Harbor perspectives in biology</Title>
          <ISOAbbreviation>Cold Spring Harb Perspect Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">a022137</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1101/cshperspect.a022137</ELocationID>
        <Abstract>
          <AbstractText>Cytokines of the transforming growth factor β (TGF-β) family, including TGF-βs, bone morphogenic proteins (BMPs), activins, and Nodal, play crucial roles in embryonic development and adult tissue homeostasis by regulating cell proliferation, survival, and differentiation, as well as stem-cell self-renewal and lineage-specific differentiation. Smad proteins are critical downstream mediators of these signaling activities. In addition to regulating the transcription of direct target genes of TGF-β, BMP, activin, or Nodal, Smad proteins also participate in extensive cross talk with other signaling pathways, often in a cell-type- or developmental stage-specific manner. These combinatorial signals often produce context-, time-, and location-dependent biological outcomes that are critical for development. This review discusses recent progress in our understanding of the cross talk between Smad proteins and signaling pathways of Wnt, Notch, Hippo, Hedgehog (Hh), mitogen-activated protein (MAP), kinase, phosphoinositide 3-kinase (PI3K)-Akt, nuclear factor κB (NF-κB), and Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathways.</AbstractText>
          <CopyrightInformation>Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Kunxin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Cell Biology, University of California, Berkeley, and Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>01</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cold Spring Harb Perspect Biol</MedlineTA>
        <NlmUniqueID>101513680</NlmUniqueID>
        <ISSNLinking>1943-0264</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051785">Smad Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051153">Wnt Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051785" MajorTopicYN="N">Smad Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051153" MajorTopicYN="N">Wnt Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>11</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27836834</ArticleId>
        <ArticleId IdType="pmc">PMC5204325</ArticleId>
        <ArticleId IdType="doi">10.1101/cshperspect.a022137</ArticleId>
        <ArticleId IdType="pii">cshperspect.a022137</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Adhikari A, Xu M, Chen ZJ. 2007. 
Ubiquitin-mediated activation of TAK1 and IKK. Oncogene
26: 3214–3226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17496917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcón C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al.
2009. 
Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell
139: 757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massagué J, Macias MJ. 2011. 
A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev
25: 1275–1288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3127429</ArticleId>
            <ArticleId IdType="pubmed">21685363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. 2013. 
A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell
154: 1047–1059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23954413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, et al.
2003. 
Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: Implications in liver tumor formation. Oncogene
22: 412–425.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12545162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. 2004. 
Phosphatidylinositol 3-kinase is involved in α2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol
172: 7123–7135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15153536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attisano L, Labbé E. 2004. 
TGFβ and Wnt pathway cross-talk. Cancer Metastasis Rev
23: 53–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15000149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attisano L, Wrana JL. 2000. 
Smads as transcriptional comodulators. Curr Opin Cell Biol
12: 235–243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10712925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. 2000. 
Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem
275: 36803–36810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10969078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, Wrana JL. 2013. 
Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep
5: 1611–1624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24332857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S. 2008. 
Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS ONE
3: e2863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2483937</ArticleId>
            <ArticleId IdType="pubmed">18682850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Böttinger EP. 2000. 
A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev
14: 187–197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316349</ArticleId>
            <ArticleId IdType="pubmed">10652273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, Lendahl U, Ibanez CF. 2003. 
Cross-talk between the Notch and TGF-β signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol
163: 723–728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2173673</ArticleId>
            <ArticleId IdType="pubmed">14638857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bozulic L, Hemmings BA. 2009. 
PIKKing on PKB: Regulation of PKB activity by phosphorylation. Curr Opin Cell Biol
21: 256–261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19303758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandl M, Seidler B, Haller F, Adamski J, Schmid RM, Saur D, Schneider G. 2010. 
IKKα controls canonical TGFβ-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J Cell Sci
123: 4231–4239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21081648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bright JJ, Sriram S. 1998. 
TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol
161: 1772–1777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9712043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brodin G, Ahgren A, ten Dijke P, Heldin CH, Heuchel R. 2000. 
Efficient TGF-β induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J Biol Chem
275: 29023–29030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10843994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burdon T, Stracey C, Chambers I, Nichols J, Smith A. 1999. 
Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol
210: 30–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10364425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996. 
TRAF6 is a signal transducer for interleukin-1. Nature
383: 443–446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8837778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlson ME, Hsu M, Conboy IM. 2008. 
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature
454: 528–532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7761661</ArticleId>
            <ArticleId IdType="pubmed">18552838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, et al.
2008. 
Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell
133: 1106–1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18555785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ. 2008. 
Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J Biol Chem
283: 1293–1307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18024957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. 2008. 
Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev
22: 746–755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2275428</ArticleId>
            <ArticleId IdType="pubmed">18347094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K. 2004. 
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis. Nat Cell Biol
6: 366–372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15104092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crease DJ, Dyson S, Gurdon JB. 1998. 
Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci
95: 4398–4403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC22500</ArticleId>
            <ArticleId IdType="pubmed">9539748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cui Y, Tian Q, Christian JL. 1996. 
Synergistic effects of Vg1 and Wnt signals in the specification of dorsal mesoderm and endoderm. Dev Biol
180: 22–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8948571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cullingworth J, Hooper ML, Harrison DJ, Mason JO, Sirard C, Patek CE, Clarke AR. 2002. 
Carcinogen-induced pancreatic lesions in the mouse: Effect of Smad4 and Apc genotypes. Oncogene
21: 4696–4701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12096346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahle O, Kumar A, Kuehn MR. 2010. 
Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci Signal
3: ra48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6953396</ArticleId>
            <ArticleId IdType="pubmed">20571128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlqvist C, Blokzijl A, Chapman G, Falk A, Dannaeus K, Ibanez CF, Lendahl U. 2003. 
Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development
130: 6089–6099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14597575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Jong DS, Steegenga WT, Hendriks JM, van Zoelen EJ, Olijve W, Dechering KJ. 2004. 
Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochem Biophys Res Commun
320: 100–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15207708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennler S, André J, Alexaki I, Li A, Magnaldo T, ten Dijke P, Wang XJ, Verrecchia F, Mauviel A. 2007. 
Induction of sonic hedgehog mediators by transforming growth factor-β: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res
67: 6981–6986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17638910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennler S, André J, Verrecchia F, Mauviel A. 2009. 
Cloning of the human GLI2 promoter: Transcriptional activation by transforming growth factor-β via SMAD3/β-catenin cooperation. J Biol Chem
284: 31523–31531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2797221</ArticleId>
            <ArticleId IdType="pubmed">19797115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Descargues P, Sil AK, Sano Y, Korchynskyi O, Han G, Owens P, Wang XJ, Karin M. 2008. 
IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci
105: 2487–2492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268163</ArticleId>
            <ArticleId IdType="pubmed">18268325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dey N, Ghosh-Choudhury N, Kasinath BS, Choudhury GG. 2012. 
TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion. PLoS ONE
7: e42316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3411779</ArticleId>
            <ArticleId IdType="pubmed">22879939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. 2007. 
Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell
130: 1120–1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666353</ArticleId>
            <ArticleId IdType="pubmed">17889654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowdy SC, Mariani A, Janknecht R. 2003. 
HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor β inhibitor Smad7 via the ETS protein ER81. J Biol Chem
278: 44377–44384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12947087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Downward J. 2004. 
PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol
15: 177–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15209377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al.
2011. 
Role of YAP/TAZ in mechanotransduction. Nature
474: 179–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M. 2003. 
Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell
14: 529–544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC149990</ArticleId>
            <ArticleId IdType="pubmed">12589052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edson MA, Nalam RL, Clementi C, Franco HL, Demayo FJ, Lyons KM, Pangas SA, Matzuk MM. 2010. 
Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol
24: 1251–1266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2875809</ArticleId>
            <ArticleId IdType="pubmed">20363875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eivers E, Fuentealba LC, Sander V, Clemens JC, Hartnett L, De Robertis EM. 2009. 
Mad is required for wingless signaling in wing development and segment patterning in Drosophila. PLoS ONE
4: e6543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2717371</ArticleId>
            <ArticleId IdType="pubmed">19657393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eivers E, Demagny H, Choi RH, De Robertis EM. 2011. 
Phosphorylation of Mad controls competition between wingless and BMP signaling. Sci Signal
4: ra68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3215398</ArticleId>
            <ArticleId IdType="pubmed">21990430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekman M, Mu Y, Lee SY, Edlund S, Kozakai T, Thakur N, Tran H, Qian J, Groeden J, Heldin CH, et al.
2012. 
APC and Smad7 link TGFβ type I receptors to the microtubule system to promote cell migration. Mol Biol Cell
23: 2109–2121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3364175</ArticleId>
            <ArticleId IdType="pubmed">22496417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Estaras C, Benner C, Jones KA. 2015. 
SMADs and YAP compete to control elongation of β-catenin: LEF-1-recruited RNAPII during hESC differentiation. Mol Cell
58: 780–793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5315497</ArticleId>
            <ArticleId IdType="pubmed">25936800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fei C, Li Z, Li C, Chen Y, Chen Z, He X, Mao L, Wang X, Zeng R, Li L. 2013. 
Smurf1-mediated Lys29-linked nonproteolytic polyubiquitination of axin negatively regulates Wnt/β-catenin signaling. Mol Cell Biol
33: 4095–4105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3811687</ArticleId>
            <ArticleId IdType="pubmed">23959799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng XH, Derynck R. 2005. 
Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol
21: 659–693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16212511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrigno O, Lallemand F, Verrecchia F, L’Hoste S, Camonis J, Atfi A, Mauviel A. 2002. 
Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene
21: 4879–4884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12118366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C. 2013. 
TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene
32: 1549–1559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3434281</ArticleId>
            <ArticleId IdType="pubmed">22641218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM. 2007. 
Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell
131: 980–993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2200633</ArticleId>
            <ArticleId IdType="pubmed">18045539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, et al.
2012. 
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med
209: 479–494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3302232</ArticleId>
            <ArticleId IdType="pubmed">22329991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. 1996. 
Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity
5: 449–460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8934572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. 2001. 
Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway. Mol Cell Biol
21: 5132–5141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87238</ArticleId>
            <ArticleId IdType="pubmed">11438668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galliher AJ, Schiemann WP. 2007. 
Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res
67: 3752–3758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17440088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. 2002. 
Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem
277: 33361–3368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12084724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. 2008. 
TGF-β coordinately activates TAK1/MEK/AKT/NFκB and SMAD pathways to promote osteoclast survival. Exp Cell Res
314: 2725–2738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2578840</ArticleId>
            <ArticleId IdType="pubmed">18586026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gudey SK, Sundar R, Mu Y, Wallenius A, Zang G, Bergh A, Heldin CH, Landström M. 2014. 
TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin 1. Sci Signal
7: ra2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24399296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X, Wang XF. 2009. 
Signaling cross-talk between TGF-β/BMP and other pathways. Cell Res
19: 71–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3606489</ArticleId>
            <ArticleId IdType="pubmed">19002158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. 2008. 
Axin and GSK3- control Smad3 protein stability and modulate TGF-β signaling. Genes Dev
22: 106–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2151009</ArticleId>
            <ArticleId IdType="pubmed">18172167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamamoto T, Beppu H, Okada H, Kawabata M, Kitamura T, Miyazono K, Kato M. 2002. 
Compound disruption of Smad2 accelerates malignant progression of intestinal tumors in Apc knockout mice. Cancer Res
62: 5955–5961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12384562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao Y, Chun A, Cheung K, Rashidi B, Yang X. 2008. 
Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem
283: 5496–5509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18158288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, et al.
2004. 
BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet
36: 1117–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15378062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heldin CH, Moustakas A. 2011. 
Role of Smads in TGFβ signaling. Cell Tissue Res
347: 21–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21643690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heldin CH, Landstrom M, Moustakas A. 2009. 
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol
21: 166–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19237272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hinz M, Scheidereit C. 2013. 
The IκB kinase complex in NF-κB regulation and beyond. EMBO Rep
15: 46–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4303448</ArticleId>
            <ArticleId IdType="pubmed">24375677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogan KA, Ravindran A, Podolsky MA, Glick AB. 2013. 
The TGFβ1 pathway is required for NFκB-dependent gene expression in mouse keratinocytes. Cytokine
64: 652–659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3942663</ArticleId>
            <ArticleId IdType="pubmed">24075100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, et al.
2011. 
Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science
332: 358–361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3111087</ArticleId>
            <ArticleId IdType="pubmed">21493862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoppler S, Moon RT. 1998. 
BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech Dev
71: 119–129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9507084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, Cui Z, Thannickal VJ. 2004. 
Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-β1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem
279: 1359–1367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1360222</ArticleId>
            <ArticleId IdType="pubmed">14576166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hudson C, Yasuo H. 2006. 
A signalling relay involving Nodal and Delta ligands acts during secondary notochord induction in Ciona embryos. Development
133: 2855–2864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16835438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hudson C, Lotito S, Yasuo H. 2007. 
Sequential and combinatorial inputs from Nodal, Delta2/Notch and FGF/MEK/ERK signalling pathways establish a grid-like organisation of distinct cell identities in the ascidian neural plate. Development
134: 3527–3537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17728350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hui CC, Angers S. 2011. 
Gli proteins in development and disease. Annu Rev Cell Dev Biol
27: 513–537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21801010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussein SM, Duff EK, Sirard C. 2003. 
Smad4 and β-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem
278: 48805–48814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14551209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, et al.
1996. 
Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem
271: 28745–28748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8910514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishinaga H, Jono H, Lim JH, Kweon SM, Xu H, Ha UH, Koga T, Yan C, Feng XH, Chen LF, et al.
2007. 
TGF-β induces p65 acetylation to enhance bacteria-induced NF-κB activation. EMBO J
26: 1150–1162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1852843</ArticleId>
            <ArticleId IdType="pubmed">17268554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M, ten Dijke P. 2004. 
Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J
23: 541–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1271801</ArticleId>
            <ArticleId IdType="pubmed">14739937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jahchan NS, Wang D, Bissell MJ, Luo K. 2012. 
SnoN regulates mammary gland alveologenesis and onset of lactation by promoting prolactin/Stat5 signaling. Development
139: 3147–3156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3413161</ArticleId>
            <ArticleId IdType="pubmed">22833129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, Mauviel A. 2011. 
TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res
71: 5606–5610.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3165102</ArticleId>
            <ArticleId IdType="pubmed">21862631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javelaud D, Pierrat MJ, Mauviel A. 2012. 
Crosstalk between TGF-β and hedgehog signaling in cancer. FEBS Lett
586: 2016–2025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22609357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeong HW, Kim IS. 2004. 
TGF-β1 enhances βig-h3-mediated keratinocyte cell migration through the α3β1 integrin and PI3K. J Cell Biochem
92: 770–780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15211574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jian H, Shen X, Liu I, Semenov M, He X, Wang XF. 2006. 
Smad3-dependent nuclear translocation of β-catenin is required for TGF-β1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev
20: 666–674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1413283</ArticleId>
            <ArticleId IdType="pubmed">16543220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. 2006. 
BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Mol Cells
22: 353–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17202865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. 2011. 
TGF-β promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res
71: 822–831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3077118</ArticleId>
            <ArticleId IdType="pubmed">21189326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung SM, Lee JH, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae YS, et al.
2013. 
Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun
4: 2562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24096742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, et al.
2009. 
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol
11: 881–889.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2744130</ArticleId>
            <ArticleId IdType="pubmed">19543271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S, Jho EH. 2010. 
The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem
285: 36420–36426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2978571</ArticleId>
            <ArticleId IdType="pubmed">20858899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SW, Yoon SJ, Chuong E, Oyolu C, Wills AE, Gupta R, Baker J. 2011. 
Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev Biol
357: 492–504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21741376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Kim JG, Moon MY, Park SH, Park JB. 2014. 
IκB kinase γ/nuclear factor-κB-essential modulator (IKKγ/NEMO) facilitates RhoA GTPase activation, which, in turn, activates Rho-associated KINASE (ROCK) to phosphorylate IKKβ in response to transforming growth factor (TGF)-β1. J Biol Chem
289: 1429–1440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3894326</ArticleId>
            <ArticleId IdType="pubmed">24240172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kimelman D, Griffin KJ. 2000. 
Vertebrate mesendoderm induction and patterning. Curr Opin Genet Dev
10: 350–356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10889062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, Komuro A, Kano MR, Sugimoto K, Miyazono K. 2009. 
Autophagy is activated by TGF-β and potentiates TGF-β-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res
69: 8844–8852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19903843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleber M, Lee HY, Wurdak H, Buchstaller J, Riccomagno MM, Ittner LM, Suter U, Epstein DJ, Sommer L. 2005. 
Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell Biol
169: 309–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2171862</ArticleId>
            <ArticleId IdType="pubmed">15837799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kon A, Vindevoghel L, Kouba DJ, Fujimura Y, Uitto J, Mauviel A. 1999. 
Cooperation between SMAD and NF-κB in growth factor regulated type VII collagen gene expression. Oncogene
18: 1837–1844.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10086338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krausova M, Korinek V. 2014. 
Wnt signaling in adult intestinal stem cells and cancer. Cell Signal
26: 570–579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24308963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kretzschmar M, Doody J, Massagué J. 1997. 
Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature
389: 618–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. 2007. 
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development
134: 2895–2902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17660198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuroda H, Fuentealba L, Ikeda A, Reversade B, De Robertis EM. 2005. 
Default neural induction: Neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev
19: 1022–1027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1091736</ArticleId>
            <ArticleId IdType="pubmed">15879552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbé E, Letamendia A, Attisano L. 2000. 
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci
97: 8358–8363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC26952</ArticleId>
            <ArticleId IdType="pubmed">10890911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamouille S, Derynck R. 2007. 
Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol
178: 437–451.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064840</ArticleId>
            <ArticleId IdType="pubmed">17646396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. 2012. 
TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci
125: 1259–1273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3324583</ArticleId>
            <ArticleId IdType="pubmed">22399812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landström M. 2010. 
The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol
42: 585–589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20060931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larrivée B, Prahst C, Gordon E, del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A. 2012. 
ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell
22: 489–500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4047762</ArticleId>
            <ArticleId IdType="pubmed">22421041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, Derynck R. 1997. 
The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem
272: 14850–14859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9169454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lechuga CG, Hernandez-Nazara ZH, Dominguez Rosales JA, Morris ER, Rincon AR, Rivas-Estilla AM, Esteban-Gamboa A, Rojkind M. 2004. 
TGF-β1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6K. Am J Physiol Gastrointest Liver Physiol
287: G974–G987.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15246963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee YI, Kwon YJ, Joo CK. 2004. 
Integrin-linked kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun
316: 997–1001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15044083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. 
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J
26: 3957–3967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1994119</ArticleId>
            <ArticleId IdType="pubmed">17673906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC. 2004. 
The murine gastrin promoter is synergistically activated by transforming growth factor-β/Smad and Wnt signaling pathways. J Biol Chem
279: 42492–42502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15292219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL. 2008. 
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol
28: 2426–2436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268418</ArticleId>
            <ArticleId IdType="pubmed">18227151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lengerke C, Schmitt S, Bowman TV, Jang IH, Maouche-Chrétien L, McKinney-Freeman S, Davidson AJ, Hammerschmidt M, Rentzsch F, Green JB, et al.
2008. 
BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell
2: 72–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18371423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li WX. 2008. 
Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol
18: 545–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3082280</ArticleId>
            <ArticleId IdType="pubmed">18848449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Fei T, Zhang J, Zhu G, Wang L, Lu D, Chi X, Teng Y, Hou N, Yang X, et al.
2012. 
BMP4 Signaling Acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell
10: 171–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22305567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, et al.
2010. 
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev
24: 1106–1118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2878649</ArticleId>
            <ArticleId IdType="pubmed">20516196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang M, Liang YY, Wrighton K, Ungermannova D, Wang XP, Brunicardi FC, Liu X, Feng XH, Lin X. 2004. 
Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol
24: 7524–7537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC506984</ArticleId>
            <ArticleId IdType="pubmed">15314162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM, Wang XF. 1999. 
Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci
96: 4844–4849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC21779</ArticleId>
            <ArticleId IdType="pubmed">10220381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim JH, Jono H, Komatsu K, Woo CH, Lee J, Miyata M, Matsuno T, Xu X, Huang Y, Zhang W, et al.
2012. 
CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt. Nat Commun
3: 771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3337989</ArticleId>
            <ArticleId IdType="pubmed">22491319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu C, Xu P, Lamouille S, Xu J, Derynck R. 2009. 
TACE-mediated ectodomain shedding of the type I TGF-β receptor downregulates TGF-β signaling. Mol Cell
35: 26–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2740991</ArticleId>
            <ArticleId IdType="pubmed">19595713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, Chan SW, Lim CJ, Hong W, et al.
2010. 
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFβ-TrCP E3 ligase. J Biol Chem
285: 37159–37169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2988322</ArticleId>
            <ArticleId IdType="pubmed">20858893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Liu H, Meyer C, Li J, Nadalin S, Konigsrainer A, Weng H, Dooley S, ten Dijke P. 2013. 
Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J Biol Chem
288: 30708–30719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3798541</ArticleId>
            <ArticleId IdType="pubmed">24005672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loose M, Patient R. 2004. 
A genetic regulatory network for Xenopus mesendoderm formation. Dev Biol
271: 467–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15223347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R, Ventura F. 2000. 
Interaction and functional cooperation of NF-κB with Smads. Transcriptional regulation of the JunB promoter. J Biol Chem
275: 28937–28946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10874048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandal CC, Ghosh Choudhury G, Ghosh-Choudhury N. 2009. 
Phosphatidylinositol 3 kinase/Akt signal relay cooperates with Smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology
150: 4989–4998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2775973</ArticleId>
            <ArticleId IdType="pubmed">19819979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao R, Fan Y, Mou Y, Zhang H, Fu S, Yang J. 2011. 
TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation. Cell Signal
23: 222–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2956842</ArticleId>
            <ArticleId IdType="pubmed">20837137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J. 2012. 
TGFβ signalling in context. Nat Rev Mol Cell Biol
13: 616–630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4027049</ArticleId>
            <ArticleId IdType="pubmed">22992590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda S, Kumano K, Shimizu K, Imai Y, Kurokawa M, Ogawa S, Miyagishi M, Taira K, Hirai H, Chiba S. 2005. 
Notch1 oncoprotein antagonizes TGF-β/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci
96: 274–282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15904468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuura I, Wang G, He D, Liu F. 2005. 
Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry
44: 12546–12553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16156666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maurya AK, Tan H, Souren M, Wang X, Wittbrodt J, Ingham PW. 2011. 
Integration of Hedgehog and BMP signalling by the engrailed2a gene in the zebrafish myotome. Development
138: 755–765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21266411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Millet C, Yamashita M, Heller M, Yu LR, Veenstra TD, Zhang YE. 2009. 
A negative feedback control of transforming growth factor-β signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem
284: 19808–19816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2740406</ArticleId>
            <ArticleId IdType="pubmed">19458083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohammad KS, Javelaud D, Fournier PG, Niewolna M, McKenna CR, Peng XH, Duong V, Dunn LK, Mauviel A, Guise TA. 2011. 
TGF-β-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res
71: 175–184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3225124</ArticleId>
            <ArticleId IdType="pubmed">21084275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M, Del Vecchio Blanco G, Tersigni R, Alessandroni L, Mann D, et al.
2004. 
A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. J Biol Chem
279: 3925–3932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14600158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mu Y, Gudey SK, Landström M. 2012. 
Non-Smad signaling pathways. Cell Tissue Res
347: 11–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21701805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullen AC, Orlando DA, Newman JJ, Loven J, Kumar RM, Bilodeau S, Reddy J, Guenther MG, DeKoter RP, Young RA. 2011. 
Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell
147: 565–576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3212730</ArticleId>
            <ArticleId IdType="pubmed">22036565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T. 1999. 
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science
284: 479–482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10205054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nallet-Staub F, Yin X, Gilbert C, Marsaud V, Ben Mimoun S, Javelaud D, Leof EB, Mauviel A. 2015. 
Cell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activation. Dev Cell
32: 640–651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4437188</ArticleId>
            <ArticleId IdType="pubmed">25758862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niimi H, Pardali K, Heldin CH, Moustakas A. 2007. 
Notch signaling is necessary for epithelial growth arrest by TGF-β. J Cell Biol
176: 695–707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064026</ArticleId>
            <ArticleId IdType="pubmed">17325209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. 
Interaction between Wnt and TGF-β signalling pathways during formation of Spemann’s organizer. Nature
403: 781–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10693808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nobta M, Tsukazaki T, Shibata Y, Xin C, Moriishi T, Sakano S, Shindo H, Yamaguchi A. 2005. 
Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem
280: 15842–15848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15695512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nostro MC, Cheng X, Keller GM, Gadue P. 2008. 
Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell
2: 60–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2533280</ArticleId>
            <ArticleId IdType="pubmed">18371422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nowell C, Radtke F. 2013. 
Cutaneous Notch signaling in health and disease. Cold Spring Harb Perspect Med
3: a017772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3839599</ArticleId>
            <ArticleId IdType="pubmed">24296353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusse R. 2012. 
Wnt signaling. Cold Spring Harb Perspect Biol
4: a011163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3331700</ArticleId>
            <ArticleId IdType="pubmed">22550232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nye MD, Almada LL, Fernandez-Barrena MG, Marks DL, Elsawa SF, Vrabel A, Tolosa EJ, Ellenrieder V, Fernandez-Zapico ME. 2014. 
The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner. J Biol Chem
289: 15495–15506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4140905</ArticleId>
            <ArticleId IdType="pubmed">24739390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa K, Chen F, Kuang C, Chen Y. 2004. 
Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by a nuclear factor-κB site. Biochem J
381: 413–422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1133847</ArticleId>
            <ArticleId IdType="pubmed">15086314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh H, Irvine KD. 2011. 
Cooperative regulation of growth by Yorkie and Mad through Bantam. Dev Cell
20: 109–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3033745</ArticleId>
            <ArticleId IdType="pubmed">21238929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oka T, Mazack V, Sudol M. 2008. 
Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem
283: 27534–27546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18640976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ota M, Sasaki H. 2008. 
Mammalian TEAD proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development
135: 4059–4069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19004856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pardoux C, Ma X, Gobert S, Pellegrini S, Mayeux P, Gay F, Trinchieri G, Chouaib S. 1999. 
Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-β: Relationship with IL-12 signaling. Blood
93: 1448–1455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10029570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HW, Guan KL. 2013. 
Regulation of the Hippo pathway and implications for anticancer drug development. Trends Pharmacol Sci
34: 581–589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3929107</ArticleId>
            <ArticleId IdType="pubmed">24051213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perrot CY, Javelaud D, Mauviel A. 2013. 
Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment. Pharmacol Ther
137: 183–199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23063491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccolo S, Dupont S, Cordenonsi M. 2014. 
The biology of YAP/TAZ: Hippo signaling and beyond. Physiol Rev
94: 1287–1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25287865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quijano JC, Stinchfield MJ, Zerlanko B, Gibbens YY, Takaesu NT, Hyman-Walsh C, Wotton D, Newfeld SJ. 2010. 
The Sno oncogene antagonizes Wingless signaling during wing development in Drosophila. PLoS ONE
5: e11619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2905394</ArticleId>
            <ArticleId IdType="pubmed">20661280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quijano JC, Stinchfield MJ, Newfeld SJ. 2011. 
Wg signaling via Zw3 and Mad restricts self-renewal of sensory organ precursor cells in Drosophila. Genetics
189: 809–824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3213367</ArticleId>
            <ArticleId IdType="pubmed">21868604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao P, Kadesch T. 2003. 
The intracellular form of Notch blocks transforming growth factor β-mediated growth arrest in Mv1Lu epithelial cells. Mol Cell Biol
23: 6694–6701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC193715</ArticleId>
            <ArticleId IdType="pubmed">12944493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rashidian J, Le Scolan E, Ji X, Zhu Q, Mulvihill MM, Nomura D, Luo K. 2015. 
Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Sci Signal
8: ra14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4457509</ArticleId>
            <ArticleId IdType="pubmed">25670202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC. 1995. 
Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem
270: 25715–25721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7592751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Remy I, Montmarquette A, Michnick SW. 2004. 
PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol
6: 358–365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15048128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rios I, Alvarez-Rodriguez R, Marti E, Pons S. 2004. 
BMP2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development
131: 3159–3168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15197161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM. 2000. 
Structure, function, and biology of SHIP proteins. Genes Dev
14: 505–520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10716940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross KR, Corey DA, Dunn JM, Kelley TJ. 2007. 
SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal
19: 923–931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17197157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Runyan CE, Schnaper HW, Poncelet AC. 2004. 
The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-β1. J Biol Chem
279: 2632–2639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14610066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saha D, Datta PK, Beauchamp RD. 2001. 
Oncogenic ras represses transforming growth factor-β/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem
276: 29531–29537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11371552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massagué J. 2007. 
Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell
25: 441–454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17289590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, et al.
2011. 
Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell
145: 926–940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3930331</ArticleId>
            <ArticleId IdType="pubmed">21663795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schohl A, Fagotto F. 2002. 
β-catenin, MAPK and Smad signaling during early Xenopus development. Development
129: 37–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11782399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seoane J, Le HV, Shen L, Anderson SA, Massagué J. 2004. 
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell
117: 211–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15084259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimmi O, Newfeld SJ. 2013. 
New insights into extracellular and post-translational regulation of TGF-β family signalling pathways. J Biochem
154: 11–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3693483</ArticleId>
            <ArticleId IdType="pubmed">23698094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y, Menendez L, Kulik M, Dalton S. 2012. 
Signaling network crosstalk in human pluripotent cells: A Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell
10: 312–326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3294294</ArticleId>
            <ArticleId IdType="pubmed">22385658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landstrom M. 2008. 
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol
10: 1199–1207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18758450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stavridis MP, Lunn JS, Collins BJ, Storey KG. 2007. 
A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development
134: 2889–2894.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17660197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN. 2012. 
Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther
11: 1587–1597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3392529</ArticleId>
            <ArticleId IdType="pubmed">22553355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun Y, Lowther W, Kato K, Bianco C, Kenney N, Strizzi L, Raafat D, Hirota M, Khan NI, Bargo S, et al.
2005. 
Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-β signaling. Oncogene
24: 5365–5374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16007227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szeto DP, Kimelman D. 2004. 
Combinatorial gene regulation by BMP and Wnt in zebrafish posterior mesoderm formation. Development
131: 3751–3760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15240553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. 1998. 
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell
92: 645–656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9506519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takaku K, Wrana JL, Robertson EJ, Taketo MM. 2002. 
No effects of Smad2 (Madh2) null mutation on malignant progression of intestinal polyps in ApcΔ716 knockout mice. Cancer Res
62: 4558–4561.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12183405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H. 2002. 
Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J
21: 6473–6482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC136947</ArticleId>
            <ArticleId IdType="pubmed">12456654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takizawa T, Ochiai W, Nakashima K, Taga T. 2003. 
Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res
31: 5723–5731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC206475</ArticleId>
            <ArticleId IdType="pubmed">14500836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teo AK, Arnold SJ, Trotter MW, Brown S, Ang LT, Chng Z, Robertson EJ, Dunn NR, Vallier L. 2011. 
Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev
25: 238–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3034899</ArticleId>
            <ArticleId IdType="pubmed">21245162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tezuka K, Yasuda M, Watanabe N, Morimura N, Kuroda K, Miyatani S, Hozumi N. 2002. 
Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res
17: 231–239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11811553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Theil T, Aydin S, Koch S, Grotewold L, Ruther U. 2002. 
Wnt and BMP signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. Development
129: 3045–3054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12070081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trompouki E, Bowman TV, Lawton LN, Fan ZP, Wu DC, DiBiase A, Martin CS, Cech JN, Sessa AK, Leblanc JL, et al.
2011. 
Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell
147: 577–589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3219441</ArticleId>
            <ArticleId IdType="pubmed">22036566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W, Nihei H. 2001. 
Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Biochem Biophys Res Commun
289: 376–381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11716483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ulloa L, Doody J, Massagué J. 1999. 
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature
397: 710–713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10067896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. 
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol
10: 837–848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18568018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinals F, Pouysségur J. 2001. 
Transforming growth factor β1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling. Mol Cell Biol
21: 7218–7230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC99897</ArticleId>
            <ArticleId IdType="pubmed">11585905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waddell DS, Liberati NT, Guo X, Frederick JP, Wang XF. 2004. 
Casein kinase Iɛ plays a functional role in the transforming growth factor-β signaling pathway. J Biol Chem
279: 29236–29246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15133026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. 
TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature
412: 346–351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11460167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G, Matsuura I, He D, Liu F. 2009a. 
Transforming growth factor-β-inducible phosphorylation of Smad3. J Biol Chem
284: 9663–9673.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2665087</ArticleId>
            <ArticleId IdType="pubmed">19218245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang K, Degerny C, Xu M, Yang XJ. 2009b. 
YAP, TAZ, and Yorkie: A conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol
87: 77–91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19234525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, Lin X, Feng XH. 2015. 
STAT3 selectively interacts with Smad3 to antagonize TGF-β. Oncogene
10.1038/onc.2015.446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2015.446</ArticleId>
            <ArticleId IdType="pmc">PMC4885808</ArticleId>
            <ArticleId IdType="pubmed">26616859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB. 2005. 
Transforming growth factor-β activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res
65: 10431–10440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16288034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong C, Rougier-Chapman EM, Frederick JP, Datto MB, Liberati NT, Li JM, Wang XF. 1999. 
Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β. Mol Cell Biol
19: 1821–1830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC83975</ArticleId>
            <ArticleId IdType="pubmed">10022869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Liu Y, Zheng Y, Dong J, Pan D. 2008. 
The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell
14: 388–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18258486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xanthos JB, Kofron M, Tao Q, Schaible K, Wylie C, Heasman J. 2002. 
The roles of three signaling pathways in the formation and function of the Spemann organizer. Development
129: 4027–4043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12163406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia ZP, Sun L, Chen X, Pineda G, Jiang X, Adhikari A, Zeng W, Chen ZJ. 2009. 
Direct activation of protein kinases by unanchored polyubiquitin chains. Nature
461: 114–119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2747300</ArticleId>
            <ArticleId IdType="pubmed">19675569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia H, Ooi LL, Hui KM. 2013. 
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology
58: 629–641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23471579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu X, Han J, Ito Y, Bringas P Jr, Deng C, Chai Y. 2008. 
Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-β/BMP signaling during tooth and palate development. Dev Cell
15: 322–329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2610417</ArticleId>
            <ArticleId IdType="pubmed">18694570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. 
Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science
270: 2008–2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8533096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. 2008. 
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell
31: 918–924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2621323</ArticleId>
            <ArticleId IdType="pubmed">18922473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeh YY, Chiao CC, Kuo WY, Hsiao YC, Chen YJ, Wei YY, Lai TH, Fong YC, Tang CH. 2008. 
TGF-β1 increases motility and αvβ3 integrin up-regulation via PI3K, Akt and NF-κB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol
75: 1292–1301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18191107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying QL, Nichols J, Chambers I, Smith A. 2003. 
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell
115: 281–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14636556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF. 1997. 
Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol Cell Biol
17: 7019–7028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC232558</ArticleId>
            <ArticleId IdType="pubmed">9372933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshida-Koide U, Matsuda T, Saikawa K, Nakanuma Y, Yokota T, Asashima M, Koide H. 2004. 
Involvement of Ras in extraembryonic endoderm differentiation of embryonic stem cells. Biochem Biophys Res Commun
313: 475–481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14697213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Guan KL. 2013. 
The Hippo pathway: Regulators and regulations. Genes Dev
27: 355–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3589553</ArticleId>
            <ArticleId IdType="pubmed">23431053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu P, Pan G, Yu J, Thomson JA. 2011. 
FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell
8: 326–334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3052735</ArticleId>
            <ArticleId IdType="pubmed">21362572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zamurovic N, Cappellen D, Rohner D, Susa M. 2004. 
Coordinated activation of notch, Wnt, and transforming growth factor-β signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem
279: 37704–37715.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15178686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. 2004. 
Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J
23: 1155–1165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC380966</ArticleId>
            <ArticleId IdType="pubmed">14976548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Feng XH, Derynck R. 1998. 
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature
394: 909–913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9732876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. 2008. 
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell
14: 377–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2292673</ArticleId>
            <ArticleId IdType="pubmed">18258485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S, Xiong Y, Lei QY, Guan KL. 2009. 
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem
284: 13355–13362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2679435</ArticleId>
            <ArticleId IdType="pubmed">19324877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, et al.
2012. 
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol
14: 717–726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22706160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhou F, Garcia de Vinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al.
2013. 
TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol Cell
51: 559–572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23973329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al.
2007. 
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev
21: 2747–2761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2045129</ArticleId>
            <ArticleId IdType="pubmed">17974916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Ye X, Yu J, Li L, Li W, Li S, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, et al.
2008. 
TEAD mediates YAP-dependent gene induction and growth control. Genes Dev
22: 1962–1971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2492741</ArticleId>
            <ArticleId IdType="pubmed">18579750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Kim J, Ye X, Lai ZC, Guan KL. 2009. 
Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res
69: 1089–1098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19141641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou J, Jain S, Azad AK, Xu X, Yu HC, Xu Z, Godbout R, Fu Y. 2016. 
Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells. Cell Signal
28: 838–849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27075926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y, Ahlemeyer B, Bauerbach E, Krieglstein J. 2001. 
TGF-β1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures. Neurochem Int
38: 227–235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11099781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y, Culmsee C, Klumpp S, Krieglstein J. 2004. 
Neuroprotection by transforming growth factor-β1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience
123: 897–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14751283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Q, Le Scolan E, Jahchan N, Ji X, Xu A, Luo K. 2016. 
SnoN antagonizes the Hippo kinase complex to promote TAZ signaling during breast carcinogenesis. Dev Cell
37: 1–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4902294</ArticleId>
            <ArticleId IdType="pubmed">27237790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zoncu R, Efeyan A, Sabatini DM. 2011. 
mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol
12: 21–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390257</ArticleId>
            <ArticleId IdType="pubmed">21157483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zorn AM, Butler K, Gurdon JB. 1999. 
Anterior endomesoderm specification in Xenopus by Wnt/β-catenin and TGF-β signalling pathways. Dev Biol
209: 282–297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10328921</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
